Selecta Biosciences, Inc. (SELB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Selecta Biosciences, Inc. (SELB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Selecta Biosciences, Inc. (SELB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Selecta Biosciences, Inc. (SELB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 27, 2016
38 pages — Published Sep 27, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Selecta Biosciences, Inc. (Selecta Biosciences) is a biopharmaceutical company that develops immunotherapies and vaccines to prevent and treat disease. The companys synthetic vaccine particle platform can enable a novel approach for selectively targeting the immune system to treat and prevent rare and serious diseases. It develops products for the treatment of infections, central nervous system diseases, cancer, allergies, cardiovascular diseases, autoimmunity, metabolic diseases, asthma and acute and chronic inflammatory conditions. Selecta Biosciences pipeline products include SEL-2012, SEL-070, SEL-701, and others.

Selecta Biosciences, Inc. (SELB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major

  
Source:
Document ID
GDPH193607D
Country
Industry
Ticker
SELB=US
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Selecta Biosciences, Inc., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Selecta Biosciences, Inc., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Selecta Biosciences, Inc., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Selecta Biosciences, Inc., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Selecta Biosciences, Inc., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 201692
Selecta Biosciences, Inc., Pharmaceuticals &Healthcare, Deal Details1124
  Asset Purchase111
    Selecta Biosciences Acquires Rights to Virexxa from Kevelt111
  Venture Financing121
    Selecta Biosciences Raises USD38 Million in Series E Financing122
    Selecta Biosciences Raises More than USD20 Million in Venture Financing142
    Selecta Biosciences Raises USD4.4 Million in Venture Financing161
    Selecta Biosciences Raises USD6 Million in Venture Financing171
    Selecta Biosciences Raises USD5.3 Million in Venture Financing181
    Selecta Biosciences Secures US$47 Million In Series D Financing Round192
    Selecta Biosciences Raises US$15 Million In Series C Financing Round212
  Partnerships231
    Selecta Biosciences Enters into Research Agreement with Genethon231
    Selecta Biosciences and Juvenile Diabetes Research Foundation Enter into Co-Development Agreement with Sanofi242
    Juvenile Diabetes Research Foundation Enters Into Research Collaboration With Selecta Biosciences262
  Licensing Agreements281
    Selecta Biosciences Enters into Licensing Agreement with Massachusetts Eye and Ear Infirmary281
    Selecta Biosciences Exercises Option for Licensing Agreement with Sanofi291
    Selecta Biosciences Enters into Licensing Agreement with 3SBio for Pegsiticase301
    Selecta Biosciences Enters Into Licensing Agreement With Sanofi To Develop Antigen-Specific Immunotherapies312
  Equity Offering331
    Selecta Biosciences Raises USD70 Million in IPO332
Selecta Biosciences, Inc. - Key Competitors351
Key Employees361
Locations And Subsidiaries371
  Head Office371
Appendix381
  Methodology381
  About GlobalData381
  Contact Us381
  Disclaimer381

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Selecta Biosciences, Inc. (SELB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 27, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Selecta-Biosciences-Inc-SELB-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-6957>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Selecta Biosciences, Inc. (SELB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 27, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Selecta-Biosciences-Inc-SELB-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-6957>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research